Clinical Trials
3
Active:0
Completed:0
Trial Phases
2 Phases
Phase 2:1
Phase 3:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 3
2 (66.7%)Phase 2
1 (33.3%)Safety and Tolerability of IRX-101 in Patients Receiving Intravitreal Injections
- First Posted Date
- 2023-03-01
- Last Posted Date
- 2025-01-13
- Lead Sponsor
- iRenix Medical, Inc.
- Target Recruit Count
- 240
- Registration Number
- NCT05750589
- Locations
- 🇺🇸
R. Gary Lane, II MD, San Antonio, Texas, United States
SteRilizing Eye SoLution to ImprovE Patient ComFort (RELIEF)
- First Posted Date
- 2023-02-28
- Last Posted Date
- 2023-06-13
- Lead Sponsor
- iRenix Medical, Inc.
- Target Recruit Count
- 75
- Registration Number
- NCT05747430
- Locations
- 🇺🇸
Edward Wood, MD, Round Rock, Texas, United States
EffiCacy, Safety and ToLErability of a Novel Ocular ANtiseptic for Ocular Use (CLEAN)
Phase 3
Terminated
- Conditions
- Diabetic Macular EdemaGlaucoma/Closed Angle GlaucomaBranch Retinal Vein Occlusion
- Interventions
- Drug: Control
- First Posted Date
- 2021-11-19
- Last Posted Date
- 2022-05-24
- Lead Sponsor
- iRenix Medical, Inc.
- Target Recruit Count
- 5
- Registration Number
- NCT05127525
- Locations
- 🇺🇸
Florida, Tampa, Florida, United States
News
No news found